Gilead Sciences buying Immunomedics in $21 billion deal
By Staff | Sep 14, 2020
FILE - This April 30, 2020, file photo shows Gilead Sciences headquarters in Foster City, Calif. Shares of Immunomedics more than doubled before the market open on Monday, Sept. 14 after Gilead Sciences said it'll buy the biotechnology company for $21 billion. (AP Photo/Ben Margot, File)
SIGN UP TO CONTINUE
Print Subscriber? Sign Up for Full Access!
Please sign up for as low as 36 cents per day to continue viewing our website.
Digital subscribers receive
Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone.
Access nashuatelegraph.com, view our digital edition or use our Full Access apps.
Get more information at nashuatelegraph.com/fullaccess